Stay updated on ZUMA-2 Study Brexuca Clinical Trial
Sign up to get notified when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.
Latest updates to the ZUMA-2 Study Brexuca Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.0%
- Check32 days agoNo Change Detected
- Check48 days agoChange DetectedThe study has expanded to include 32 locations, and the website has been updated to version 2.10.0, replacing the previous version 2.9.7.SummaryDifference0.2%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check68 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.SummaryDifference0.0%
- Check73 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a clinical trial for brexucabtagene autoleucel (KTE-X19) in participants with relapsed/refractory mantle cell lymphoma.SummaryDifference0.0%
Stay in the know with updates to ZUMA-2 Study Brexuca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.